Sodium-glucose cotransporter 2 inhibitors and anemia among diabetes patients in real clinical practice.
Miho MurashimaTomohiro TanakaTakahisa KasugaiTatsuya TomonariAtsuki IdeMinamo OnoMasashi MizunoTaisei SuzukiTakayuki HamanoPublished in: Journal of diabetes investigation (2021)
The use of SGLT2i was associated with higher hemoglobin levels and lower prevalence of anemia in real clinical practice.